David G. Forcione, MD

Instructor in Medicine
Harvard Medical School

Publications:

1. Piesman M, Forcione DG. A case of pancreatic lymphoma. MedGenMed. 2007 Aug 9;9(3):32.
   
   
2. Rutherford AE, Hynan LS, Borges CB, Forcione DG, Blackard JT, Lin W, Gorman AR, Shaikh OS, Reuben A, Harrison E, Reddy KR, Le WM, Chung RT; ALF Study Group. Serum apoptosis markers in acute liver failure: a pilot study. Clin Gastroenterol Hepatol. 2007 Dec;5(12):1477-83.
   
   
3. Forcione DG, Rosen MJ, Kisiel JB, Sands BE. Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease. Gut. 2004 Aug;53(8):1117-22.
   
   
4. Forcione DG. Gastrointestinal disease in primary care Gastroenterology. 2000 Dec;119(6):1803-4.
   
   
5. Forcione DG, Sands B, Isselbacher KJ, Rustgi A, Podolsky DK, Pillai S. An increased risk of Crohn's disease in individuals who inherit the HLA class II DRB3*0301 allele. Proc Natl Acad Sci U S A. 1996 May 14;93(10):5094-8.
   
   
6. Lauwers GY. Mino M. Ban S. Forcione D . Eatherton DE. Shimizu M. Sevestre H. Cytokeratins 7 and 20 and mucin core protein expression in esophageal cervical inlet patch. American Journal of Surgical Pathology. 29(4):437-42, 2005 Apr.
   
   
7. Forcione DG. Rosen MJ. Kisiel JB. Sands BE. Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease. Gut. 53(8):1117-22, 2004 Aug.
   
   
8. Chaudhuri S, Cariappa A, Tang M, Bell D, Haber D, Isselbacher KJ, Finkelstein D, Forcione DG , Pillai S. Genetic susceptibility to breast cancer: HLA DQB*03032 and HLA DRB1*11 may represent protective alleles. Proceedings of the National Academy of Sciences of the United States of America. 97(21):11451-11454, 2000 October 10.